Arrange the following in increasing order for risk of malignancy1.Fibroadenoma2.Sclerosing adenosis3.Atypical ductal hyperplasia4.Lobular carcinoma is situ
**Core Concept**
The question requires arranging breast lesions in increasing order of their risk of malignancy. This involves understanding the histopathological characteristics and clinical significance of each lesion. The correct arrangement will be based on the relative risk of each lesion progressing to invasive carcinoma.
**Why the Correct Answer is Right**
Fibroadenoma is a benign breast tumor with a very low risk of malignancy. Sclerosing adenosis is a type of benign proliferative lesion that can mimic cancer on imaging but has a minimal risk of progressing to invasive carcinoma. Atypical ductal hyperplasia (ADH) is a precancerous lesion that has a higher risk of progressing to ductal carcinoma in situ (DCIS) and subsequently to invasive carcinoma. Lobular carcinoma in situ (LCIS) is a type of non-invasive proliferative lesion that has a higher risk of progressing to invasive lobular carcinoma. The correct order from lowest to highest risk of malignancy is fibroadenoma, sclerosing adenosis, ADH, and LCIS.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not reflect the correct order of increasing risk of malignancy. Fibroadenoma should be below sclerosing adenosis in the order.
**Option B:** This option is incorrect because it places ADH below LCIS, which is not accurate. ADH has a higher risk of progressing to invasive carcinoma than sclerosing adenosis.
**Clinical Pearl / High-Yield Fact**
When evaluating breast lesions, it is essential to consider the patient's age, family history, and imaging characteristics to determine the relative risk of malignancy. A thorough understanding of the histopathological features of each lesion is crucial for accurate diagnosis and management.
**Correct Answer:** B. Fibroadenoma, Sclerosing adenosis, Atypical ductal hyperplasia, Lobular carcinoma in situ